Helps maintain immune and mitochondrial health*1,4,6-9
Of these 50 semaglutide-treated patients that developed anti-semaglutide antibodies, 28 patients (1.6% of the overall population) developed antibodies cross-reacting with native GLP-1.The in vitro neutralizing activity of the antibodies is uncertain at this time
STEP 2, n = 595) remained after filtering for sample availability at both timepoints, individuals not on treatment at study end in both arms and quality control flags (provided by SomaLogic)
diarrhoea arises from altered gut motility, bile acid metabolism, and microbiota changes
Visual Style: Clean evidence matrix with simple labels and cautious language
[1] [6] As a compounded product, the dosing regimen may be tailored to each patients requirements, and adjustments may be made based on clinical response and tolerability